Peripheral neuropathy Board decisions

The Board granted an initial rating of 10 percent for peripheral neuropathy of the right and left lower extremities from June 8, 2017 to June 3, 2019, but denied a higher rating from June 4, 2019 forward.

The Board denied the Veteran's claims for earlier effective dates and higher initial ratings for peripheral neuropathy of both sciatic and femoral nerves in the right and left lower extremities, finding no factually ascertainable date of diagnosis or onset prior to specified dates.

The Board granted an effective date of March 25, 2019 for service connection for left and right lower extremity peripheral neuropathy and asbestosis.

The Veteran's Stage IV Hodgkin's lymphoma is permanent and total in nature, and he is entitled to DEA benefits.

The Board remanded the veteran's claims for service connection of bilateral foot disabilities and total disability rating based on individual unemployability due to service-connected disabilities. The Board found that additional medical opinions and records are needed.

The Board remanded the veteran's claims for service connection of peripheral neuropathy in all four extremities, citing deficiencies in the medical opinions and records. The VA must obtain additional records and a new medical opinion.

The veteran's initial rating for neuropathy of the right lower extremity is granted at 30 percent.

The Board granted service connection for peripheral vascular disease (PVD) as secondarily aggravated by diabetes, right leg amputation and scar as secondary to PVD, and SMC for loss of use of the right foot. The evaluation in excess of 20 percent for diabetes was denied.

The Board denied increased ratings for ischemic heart disease and right knee replacement with residuals, and remanded claims for service connection for neuropathy of the hands, feet, and erectile dysfunction.

The Board dismissed the claims for service connection for COPD, lipoma disability, eye/color vision disability, liver disability, eye/perception disability, CTS of both upper extremities, neuropathy of both lower extremities as they were subject to a prohibited concurrent election and there is no remaining case or controversy.

The Board granted an effective date of November 5, 2019 for the awards of service connection for peripheral neuropathy affecting all four extremities.

The Board denied the claims for revision of the May 2012 rating decision on the basis of clear and unmistakable error (CUE) as there was no evidence that the outcome would have been different but for the alleged errors.

The Board denied all initial rating claims for various disabilities, finding that the evidence did not support higher ratings.

The Board denied increased ratings for diabetes mellitus, type II and diabetic peripheral neuropathy of the bilateral lower extremities, but granted a 20 percent rating for diabetic peripheral neuropathy of both legs as of February 10, 2022.

The Board denied service connection for bilateral lower extremity peripheral neuropathy and bilateral upper extremity conditions, including carpel tunnel syndrome and degenerative arthritis, as the evidence did not support a finding that these conditions were related to the veteran's active military service.

The Board denied earlier effective dates for the awards of separate 20 percent ratings for right and left lower extremity femoral nerve diabetic peripheral neuropathy, as well as a rating in excess of 20 percent for diabetes mellitus.

The Board denied service connection for all the claimed conditions as there was no evidence to support a causal relationship between any of the claimed conditions and the Veteran's active military service.

The Board remanded all issues related to service connection for various disabilities, including heart disability and peripheral neuropathies. The Veteran's claims are being sent back for additional development.

The Board denied the veteran's request for an earlier effective date for a 40 percent rating increase for peripheral neuropathy in both lower extremities, stating that the symptoms did not worsen before August 13, 2018.

The Board remanded the veteran's claims for service connection for various conditions, including PTSD and peripheral neuropathy, due to conflicting medical evidence and the need for further examination.